The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
Coro, an Israel-based cybersecurity company co-founded by Technion – Israel Institute of Technology faculty, has closed an $80m funding round led by Balderton Capital, with participation from existing backer JVP, according to Globes. The company, formerly known as Coronet, had earlier raised $40m and this is its first round since 2018.
ReadySet, a US-based database infrastructure technology developer based on research at Massachusetts Institute of Technology, has raised $24m in a series A round led by Index Ventures, with participation from Amplify Partners and assorted angel investors, according to TechCrunch. ReadySet previously raised $4.9m in seed financing, disclosed together with the series A round.
Restor3d, a US-based medical device company and 3D printing manufacturer co-founded by Duke University faculty, has raised $23m from unnamed investors. The funding comes after Restor3d merged with ankle replacement company Kinos Medical last year.
Altoida, a Switzerland-based precision neurology company spun out of ETH Zurich, raised an additional $14m in series A financing at the end of last month to bring the round to $20.3m. The extension was co-led by M Ventures, the corporate venturing arm of pharmaceutical firm Merck Group, and Whitecap Venture Partners. It also attracted health system HonorHealth and Hikma Ventures, the investment vehicle for pharmaceutical company Hikma Pharmaceuticals, as well as Btov, Fyrfly and VI Partners. The second tranche comes almost three years after Altoida raised an initial $6.3m in series A financing.
Nanolive, a Switzerland-based live-cell imaging and analysis company spun out of EPFL, has raised $20m in series C1 funding co-led by Taiwania Capital and an unnamed life science investor. The round featured Swisscom Ventures, the corporate venturing arm of telecoms firm Swisscom, and unnamed existing backers. Nanolive is hoping to achieve a second close for the round in three months.
TXP Medical, the Japan-based operator of emergency medical data platform Next Stage ER, has secured ¥1.5bn ($12.2m) in series B funding from University of Tokyo’s Edge Capital Partners unit and trading firm Itochu.
Kynos Therapeutics, a UK-based immune-metabolic company spun out of University of Edinburgh, emerged from stealth today with £9m ($11.8m) in funding led by Epidarex Capital, with participation from IP Group and Scottish Enterprise. Kynos has built a pipeline focused on three key areas: critical illness following surgery, conditions driven by inflammation and cancers where inflammation prevents the immune system from targeting the disease.
Guard Medical, a US-based negative pressure wound therapy developer, closed an $11m series B round yesterday. The company did not disclose investors but said its current shareholders include Bpifrance and Matignon Investissement et Gestion. Guard Medical advances research pioneered at Cornell University’s Weill Cornell Medicine and NewYork-Presbyterian Hospital. It had raised $5m from unnamed backers in June 2020.
Gaviti, an Israel-based developer of an automation system for client invoices, has completed a $9m series A round backed by TAU Ventures, the venture capital fund aligned with Tel Aviv University. The round was led by Flashpoint and also included Moneta VC, North First Ventures and Leta Capital.
Liminal, a US-based battery manufacturing intelligence company, has pocketed $8m in series A financing co-led by University of Tokyo Edge Capital, the venture capital affiliate of the university, and Good Growth Capital. The round included Volta Energy Technologies, Helios Capital Ventures, Impact Science Ventures, Chrysalix Ventures, Elemental Excelerator and Incite.org.
Kooky, a Switzerland-based reusable cup system developer, has raised €6m ($6.6m) in a funding round led by UVC Partners, the venture capital affiliate of TU Munich’s innovation hub UnternehmerTUM. The round also attracted angel investors and will enable Kooky to expand into Germany and Austria.
NovaXS Biotech, a US-based developer of a needle-free injection system based on research at University of California, Berkeley, has completed a $1.5m seed round featuring healthcare provider Edward Elmhurst Health and medical device producer Baxter, TechCrunch reported last Thursday. Angel investor Lei Ming led the round, which included Taihill Venture, NewGen VC, Courtyard Ventures and MHub Impact Fund.
TopoLogic, the Japan-based quantum transformation technology developer spun out of University of Tokyo, has raised ¥130m ($1m) in a seed round featuring the university and venture capital firm IT-Farm Corporation.
WafR, a Morocco-based platform to run mass promotions, has raised $735,000 in funding from investors including UM6P, the venture arm of Mohammed 6 Polytechnic University, according to Techbuild Africa. The round also included Plug and Play and assorted angel investors.
PhytoChem Products, the Japan-based ion-exchange process-fuelled rice bran developer spun out of Tohoku University, has raised ¥37.7m ($304,000) from diversified chemicals producer Watanabe Chemical and an unnamed company.
Metcela, the Japan-based developer of congenital heart disease-focused regenerative therapies, has raised an undisclosed amount of funding from Osaka University Venture Capital and Tohoku University Venture Partners, respective investment subsidiaries of Osaka University and Tohoku University.
– Additional reporting by Edison Fu and Robert Lavine
